AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31606032 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard of care
Number of subjects: 0
Study 28088207 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection (specifics not provided)
Number of subjects: 60
Study 26602093 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone Cognitive Behavioral Therapy (tCBT) with motivational interviewing techniques
Number of subjects: 0
Study 26602093 — intervention group
Group type: COMPARATOR
Intervention: K6 score measured at the beginning of the session
Number of subjects: 0
Study 24051942 — intervention group
Group type: COMPARATOR
Intervention: Metformin (3 g)
Number of subjects: 0
Study 24051942 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1.7 g), myo-inositol, and alpha-lipoic acid
Number of subjects: 0
Study 21159127 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbial cellulose (MC) wound dressing
Number of subjects: 34
Study 21159127 — intervention group
Group type: COMPARATOR
Intervention: Xeroform™ Petrolatum gauze
Number of subjects: 34
Study 18781079 — intervention group
Group type: EXPERIMENTAL
Intervention: HDF
Number of subjects: 12
Study 18781079 — intervention group
Group type: COMPARATOR
Intervention: HFHD
Number of subjects: 12
Study 16520568 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate walking exercise
Number of subjects: 44
Study 16520568 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast walking exercise
Number of subjects: 44
Study 16520568 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 44
Study 12659599 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10-20 mg/d
Number of subjects: 61
Study 12659599 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 10-20 mg/d
Number of subjects: 61
Study 10849529 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated CD34+ cells
Number of subjects: 0
Study 10849529 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated apheresis collections
Number of subjects: 0
Study 10849529 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated cell group
Number of subjects: 0
Study 10849529 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 10849529 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated immunomagnetic cell selection system
Number of subjects: 0
Study 9356086 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW sedation (target Ramsay Sedation Score [RSS] = 2)
Number of subjects: 50
Study 9356086 — intervention group
Group type: COMPARATOR
Intervention: HIGH sedation (target Ramsay Sedation Score [RSS] = 4)
Number of subjects: 50
Study 9356086 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW sedation
Number of subjects: 50
Study 9356086 — intervention group
Group type: COMPARATOR
Intervention: HIGH sedation
Number of subjects: 50
Study 8415785 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra 10 minutes discussion by nurses
Number of subjects: 0
Study 8415785 — intervention group
Group type: COMPARATOR
Intervention: Routine procedure
Number of subjects: 0
Study 2428852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol 320 mg/day
Number of subjects: 56
Study 2428852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol 640 mg/day
Number of subjects: 56
Study 2428852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 2428852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol (both doses)
Number of subjects: 56
Study 30567497 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist intervention for antihypertensive medication initiation
Number of subjects: 119
Study 30567497 — intervention group
Group type: COMPARATOR
Intervention: Standard care without checklist (control)
Number of subjects: 119
Study 26822503 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal matching (PM) by an experienced expert
Number of subjects: 190
Study 26822503 — intervention group
Group type: COMPARATOR
Intervention: Online algorithm (OA)
Number of subjects: 190
Study 26822503 — intervention group
Group type: COMPARATOR
Intervention: Online search (OS)
Number of subjects: 190
Study 26822503 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal matching (PM)
Number of subjects: 190
Study 25287953 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-week cardiac rehabilitation (Group I)
Number of subjects: 47
Study 25287953 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week cardiac rehabilitation (Group II)
Number of subjects: 47
Study 22499574 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 minute continuous step task
Number of subjects: 13
Study 22499574 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 minute continuous calf raise task
Number of subjects: 13
Study 22499574 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate increase
Number of subjects: 13
Study 20224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline implementation strategies of low intensity (n = 8)
Number of subjects: 2076
Study 20224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline implementation strategies of moderate intensity (n = 12)
Number of subjects: 2076
Study 20224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline implementation strategies of high intensity (n = 12)
Number of subjects: 2076
Study 20224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate > or =125 per minute
Number of subjects: 2076
Study 20224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory rate > or =30 per minute
Number of subjects: 2076
Study 20224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration pneumonia
Number of subjects: 2076
Study 20224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematocrit <30%
Number of subjects: 2076
Study 17412473 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupentixol (4-12 mg/d)
Number of subjects: 144
Study 17412473 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (2-6 mg/d)
Number of subjects: 144
Study 17412473 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupentixol
Number of subjects: 144
Study 17412473 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 144
Study 15842549 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 10
Study 15842549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12190680 — intervention group
Group type: EXPERIMENTAL
Intervention: Total mesorectal excision (TME)
Number of subjects: 0
Study 12190680 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery (CRAB trial)
Number of subjects: 0
Study 10503165 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.2 mg once daily)
Number of subjects: 201
Study 10503165 — intervention group
Group type: COMPARATOR
Intervention: Terazosin (2 mg once daily)
Number of subjects: 201
Study 8084417 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose drink
Number of subjects: 0
Study 8084417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2683541 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural bupivacaine (bolus 20 ml followed by 10 ml/h)
Number of subjects: 20
Study 2683541 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (bolus 9 ml followed by 5 ml/h)
Number of subjects: 20
Study 2683541 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural bupivacaine
Number of subjects: 20
Study 2683541 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine
Number of subjects: 20
Study 1122015 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane at 0.2 vol.-%
Number of subjects: 50
Study 1122015 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane at 0.5 vol.-%
Number of subjects: 50
Study 1122015 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 50
Study 31652109 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 10ºC for 10 minutes
Number of subjects: 30
Study 31652109 — intervention group
Group type: COMPARATOR
Intervention: Water immersion at room temperature for 10 minutes
Number of subjects: 30
Study 31652109 — intervention group
Group type: COMPARATOR
Intervention: Control (rest for 10 minutes)
Number of subjects: 30
Study 30396181 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (inflation with a pneumatic TP of systolic blood pressure + 100 mm Hg)
Number of subjects: 60
Study 30396181 — intervention group
Group type: COMPARATOR
Intervention: Group B (inflation using the arterial occlusion pressure formula)
Number of subjects: 60
Study 30396181 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet Time (TT)
Number of subjects: 60
Study 30396181 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic-Nerve Sheath Diameter (ONSD)
Number of subjects: 60
Study 28604477 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG PET/ceCT
Number of subjects: 181
Study 28604477 — intervention group
Group type: COMPARATOR
Intervention: ceCT64
Number of subjects: 181
Study 26663024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for women with ≤5.5 hot flashes per day, N = 103
Number of subjects: 306
Study 26663024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for women with >5.5-8.8 hot flashes per day, N = 103
Number of subjects: 306
Study 26663024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for women with >8.8 hot flashes per day, N = 100
Number of subjects: 306
Study 26663024 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for all women
Number of subjects: 306
Study 26663024 — intervention group
Group type: COMPARATOR
Intervention: Cortisol values by hot flash frequency tertile
Number of subjects: 306
Study 25037988 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruption group (single aspirin treatment after thienopyridine interruption)
Number of subjects: 1259
Study 25037988 — intervention group
Group type: COMPARATOR
Intervention: Continuation group (DAPT continuation for 6-18 months)
Number of subjects: 1259
Study 25037988 — intervention group
Group type: COMPARATOR
Intervention: Continuation group
Number of subjects: 1259
Study 25037988 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruption group
Number of subjects: 1259
Study 22952176 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat (30 to 45 g daily)
Number of subjects: 1062
Study 22952176 — intervention group
Group type: COMPARATOR
Intervention: Multimicronutrient-fortified cereal (equicaloric to meat)
Number of subjects: 1062
Study 19949019 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib monotherapy
Number of subjects: 123
Study 19949019 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin and Paclitaxel (CP)
Number of subjects: 123
Study 19949019 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib + Carboplatin + Paclitaxel (VCP)
Number of subjects: 123
Study 18058066 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained inflation of the intrarectal balloon with 30 and 60 mL air
Number of subjects: 40
Study 18058066 — intervention group
Group type: COMPARATOR
Intervention: Rapid inflation/deflation of the intrarectal balloon with 30 and 60 mL air
Number of subjects: 40
Study 16274382 — intervention group
Group type: EXPERIMENTAL
Intervention: MHI-5
Number of subjects: 1444
Study 12126683 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable semi-rigid extension splint (Richards splint) for the first 48 hours after surgery
Number of subjects: 55
Study 12126683 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation without a splint
Number of subjects: 55
Study 9863876 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated patient visits (intervention trial)
Number of subjects: 49
Study 9863876 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient exit interviews
Number of subjects: 49
Study 9863876 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility assessments
Number of subjects: 49
Study 9863876 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions with staff
Number of subjects: 49
Study 9863876 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance data
Number of subjects: 49
Study 8554862 — intervention group
Group type: EXPERIMENTAL
Intervention: Yooralla programme (CE-based programme)
Number of subjects: 34
Study 8554862 — intervention group
Group type: COMPARATOR
Intervention: Traditional early childhood services (Control group)
Number of subjects: 34
Study 1855083 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose Vincristine (4 mg/m2), TBI (1200 cGy), Cyclophosphamide (3600 mg/m2) as standard conditioning regimen before transplant
Number of subjects: 56
Study 1855083 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine, Asta‐Z or none purging
Number of subjects: 56
Study 1855083 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated relapse
Number of subjects: 56
Study 1855083 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 56
Study 6340878 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphinpyrazone, 4 x 200 mg daily for 7 days
Number of subjects: 29
Study 6340878 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 29
Study 30986577 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy (PT)
Number of subjects: 86
Study 30986577 — intervention group
Group type: COMPARATOR
Intervention: Home exercise (HE)
Number of subjects: 86
Study 28376891 — intervention group
Group type: EXPERIMENTAL
Intervention: Aseptic technique for line management with single use intravascular catheter
Number of subjects: 249
Study 28376891 — intervention group
Group type: COMPARATOR
Intervention: Standard technique for line management
Number of subjects: 249
Study 28376891 — intervention group
Group type: EXPERIMENTAL
Intervention: Aseptic technique for line management
Number of subjects: 249
Study 25741817 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed oil
Number of subjects: 30
Study 25741817 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut oil
Number of subjects: 30
Study 25741817 — intervention group
Group type: COMPARATOR
Intervention: Control group (500 mg OD aspirin for 7 days)
Number of subjects: 30
Study 26700124 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Molecular Weight Heparin (LMWH) for 24 weeks
Number of subjects: 2202
Study 23720247 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent angina
Number of subjects: 16951
Study 23720247 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncontrolled blood pressure (≥140 mm Hg)
Number of subjects: 16951
Study 21841714 — intervention group
Group type: EXPERIMENTAL
Intervention: Solvent-assisted tape removal using water, alcohol, peanut oil, sunflower oil, and Leukotape remover
Number of subjects: 0
Study 21841714 — intervention group
Group type: COMPARATOR
Intervention: Dry tape removal
Number of subjects: 0
Study 21841714 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil (peanut and sunflower)
Number of subjects: 0
Study 19801284 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer navigation
Number of subjects: 40
Study 19801284 — intervention group
Group type: COMPARATOR
Intervention: Manual navigation
Number of subjects: 40
Study 19801284 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer navigation and Manual navigation
Number of subjects: 40
Study 17074943 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (200-800 mg/day)
Number of subjects: 289
Study 17074943 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (2-8 mg/day)
Number of subjects: 289
Study 14998418 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimization of drug prescribing
Number of subjects: 0
Study 14998418 — intervention group
Group type: EXPERIMENTAL
Intervention: Appropriate and rational prescribing
Number of subjects: 0
Study 14998418 — intervention group
Group type: EXPERIMENTAL
Intervention: Research evidence on epidemiology of prescribing
Number of subjects: 0
Study 14998418 — intervention group
Group type: EXPERIMENTAL
Intervention: Role of the prescriber and multidisciplinary team
Number of subjects: 0
Study 11708570 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron
Number of subjects: 418
Study 11708570 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg tropisetron
Number of subjects: 418
Study 11708570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study 10968848 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate tablets
Number of subjects: 305
Study 10968848 — intervention group
Group type: COMPARATOR
Intervention: Colyte
Number of subjects: 305
Study 10968848 — intervention group
Group type: COMPARATOR
Intervention: Fleet Phospho-Soda
Number of subjects: 305
Study 7625996 — intervention group
Group type: EXPERIMENTAL
Intervention: School-home note with response cost
Number of subjects: 5
Study 7625996 — intervention group
Group type: COMPARATOR
Intervention: School-home note without response cost
Number of subjects: 5
Study 2241313 — intervention group
Group type: EXPERIMENTAL
Intervention: imipenem/cilastatin
Number of subjects: 290
Study 2241313 — intervention group
Group type: COMPARATOR
Intervention: tobramycin/clindamycin
Number of subjects: 290
Study 390972 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupenthixol decanoate
Number of subjects: 64
Study 390972 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate
Number of subjects: 64
Study 31215070 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-filled catheters
Number of subjects: 33
Study 31215070 — intervention group
Group type: COMPARATOR
Intervention: Air-charged catheters
Number of subjects: 33
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) in the first and second trimester
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) in the third trimester
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) for vaginal delivery
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) for Cesarean delivery
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 3rd day after vaginal delivery
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 10th day after vaginal delivery
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 3rd day after Cesarean delivery
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 10th day after Cesarean delivery
Number of subjects: 1246
Study 27776221 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) in non-pregnant women
Number of subjects: 1246
Study 26059521 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab plus methotrexate (MTX)
Number of subjects: 0
Study 26059521 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 0
Study 23899468 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir/lamivudine (ABC/3TC)
Number of subjects: 385
Study 23899468 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir/emtricitabine (TDF/FTC)
Number of subjects: 385
Study 21972625 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep puncture at Jiaji (EX‐B 2) with round‐sharp needle
Number of subjects: 150
Study 21972625 — intervention group
Group type: COMPARATOR
Intervention: Conventional needling group (acupuncture with filiform needle)
Number of subjects: 150
Study 19491652 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine 30 mg
Number of subjects: 618
Study 19491652 — intervention group
Group type: COMPARATOR
Intervention: Stavudine 40 mg
Number of subjects: 618
Study 16911100 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib + Paracetamol
Number of subjects: 120
Study 16911100 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib alone
Number of subjects: 120
Study 16911100 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 120
Study 16911100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 15023488 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol plus SSRIs
Number of subjects: 9
Study 15023488 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus SSRIs
Number of subjects: 9
Study 11209089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Cy) plus G-CSF (arm A)
Number of subjects: 36
Study 11209089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Cy) plus GM-CSF (arm B)
Number of subjects: 36
Study 11209089 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Cy) plus GM-CSF followed by G-CSF (arm C)
Number of subjects: 36
Study 11209089 — intervention group
Group type: EXPERIMENTAL
Intervention: Good mobilizers (patients who collected a minimum of 2 x 10(6) CD34+ cells/kg)
Number of subjects: 36
Study 11209089 — intervention group
Group type: EXPERIMENTAL
Intervention: Good mobilizers
Number of subjects: 36
Study 11209089 — intervention group
Group type: EXPERIMENTAL
Intervention: SDF-1 levels
Number of subjects: 36
Study 9232040 — intervention group
Group type: EXPERIMENTAL
Intervention: Auralgan otic solution (combination product of antipyrine, benzocaine, and glycerin)
Number of subjects: 54
Study 9232040 — intervention group
Group type: COMPARATOR
Intervention: Olive oil placebo
Number of subjects: 54
Study 8356980 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose trimethoprim-sulfamethoxazole (TMP 40 mg, SMX 200 mg) once daily
Number of subjects: 129
Study 8356980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 1978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 45
Study 1978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 45